This article originally appeared on the NHCOA blog.
Health care must always meet the best standards in order to care for the population, and this can only be achieved through informed and accurate decision-making based on the results of health studies. Health care requires clinical research to find new and better treatments for diseases such as diabetes, cancer, heart conditions, etc.
Research ensures that treatments and medicines are based on scientific evidence and it ensures the safety and effectiveness of drugs. Clinical trials and research participants should be representative of the diversity of the country’s demographics, however, data show that some communities are often left out of health research.
When we look at health research on diseases that disproportionately.... Read More
Conquering Health Disparities Facing Older Hispanics
For far too many years, Hispanics across the country have been sidelined in critical medical research. As a result, our community is not taken into consideration in the creation of medical treatment programs that, for some, would be their best chance for survival. For a community that already faces a lower life expectancy, higher rates of diabetes and other critical health disparities when compared to their white peers, this reality is simply unacceptable.
Even worse is the lack of precise medical treatments for older Hispanic populations. As some of the most vulnerable members of our society, these individuals deserve equal access to.... Read More
Eczema Symptoms Found to Be Worse for African Americans
All skin – and a particular skin disorder – is not the same, as a recent study into the effects and symptoms of eczema, a frustratingly itchy, often painful and potentially embarrassing affliction of the dermis, shows.
In a study published in September in Annals of Allergy, Asthma and Immunology – the scientific journal of the American College of Allergy, Asthma and Immunology – researchers examined the molecular differences between the skin of African Americans with atopic dermatitis (the formal name for.... Read More
Advances in technology and data analysis are shaping the ways we identify, treat, and understand public health challenges like Alzheimer’s, a progressive brain disease that erodes memory and thinking skills. As the sixth leading cause of death in America, Alzheimer’s is distablizing our healthcare system, economy, and local communities. Its remarkable cost, about $277 billion annually, is even limiting the ability of states to invest in early childhood education. This multifaceted healthcare crisis is ripe for disruption and UsAgainstAlzheimer’s is fostering a dialogue on the power of tech to do just that by leveraging big data, machine learning, and digital technologies to improve detection, upskill caregivers, and to increase public awareness. Below are a few of the key areas that.... Read More
Ending the Disparate Impact of Alzheimer’s Disease on African Americans
African Americans experiencing health disparities is not new. In fact, according to former Surgeon General of the United States and Honorary Chair of the African American Network Against Alzheimer’s, Dr. David Satcher, race based health disparities in the United States are.... Read More
Every 66 seconds, someone in the United States develops Alzheimer’s disease; every minute, a family is changed forever. In the coming decades, the number of Latino families impacted by this progressive brain disease will grow dramatically due to an increase in the Latino older adult population and higher rates of of diabetes and heart disease, both risk factors for Alzheimer’s and other dementias.
Latinos comprise one of the U.S.’s largest ethnic groups, making up 17% of the U.S. population; however, they only make up 1% of those participating in clinical trials, according to data from the National Press. This is concerning as Latinos have a higher rate of chronic disease and are one of the fastest growing demographics in the nation.
Clinical trials are generally research studies that examine if a treatment or medical strategy is effective for individuals with a certain illness. Sadly, the participation of minorities in clinical trials across the United States is under-represented.
For example, according to the University of California, Davis, African Americans experience the highest.... Read More
August is National Immunization Awareness Month (NIAM), and when it comes to vaccines, it’s important to keep in mind that immunizations are not just for kids – we all need to get vaccinated at different points throughout our lifetimes. That is why it is important for older adults to know what vaccines they may need, where they are administered, and receive encouragement from their trusted health care providers and loved ones to get immunized.
The fact is that the existence of vaccines is the one of the reasons we are able to live longer, healthier lives. Diseases that used to be deadly are now preventable, and NIAM presents an opportunity to highlight the value of immunization across.... Read More